Thermo Fisher develops single system for biopharmaceutical characterisation

Thermo Fisher Scientific has developed a new single system that enables three powerful workflows for researchers performing biopharmaceutical characterisation.

The American biotechnology product development company named the tech Thermo Scientific Q Exactive BioPharma MS/MS Hybrid Quadropole-Orbitrap. The mass spectrometer harnesses the high-resolution, accurate-mass (HRAM) capabilities of the Orbitrap mass analyser.
This, says Thermo Fisher Scientific, enables three key protein characterisation workflows – denatured and native MS intact analysis, subunit and top/middle-down analysis and peptide mapping.
“Researchers require multiple MS techniques to perform the experiments essential for biopharmaceutical structure characterisation,” said Jonathan Josephs, director, pharma/biopharma marketing, life sciences mass spectrometry at Thermo Fisher.
“We now offer a single instrument that encompasses all of our leading technologies into one system, which can be used to analyse antibody-based biologics at the intact, subunit, and peptide levels—ultimately providing an efficient route to high quality results.”
Thermo Fisher Scientific is set to display the tech at:

• The 64th American Society of Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics at the Henry B. Gonzalez Convention Center in the Thermo Fisher Booth 319;
• And in the Thermo Fisher suite at the Grand Hyatt Hotel, Texas Ballroom D

For more information, visit: http://www.thermofisher.com/asms

Author

Phill Allen

Managing Director

An in and outside the (bioprocess) box thinker, fluid management specialist Phill knows a thing or two about keeping pharma liquid logistics flowing.

Follow me